Singapore markets open in 4 hours 9 minutes
Straits Times Index
3,191.16 +25.98 (+0.82%) S&P 500
4,008.01 -15.88 (-0.39%) Dow
32,223.42 +26.76 (+0.08%) Nasdaq
11,662.79 -142.21 (-1.20%) BTC-USD
29,785.54 -1,135.30 (-3.67%) CMC Crypto 200
667.04 +424.36 (+174.87%)
Roche Holding AG (ROG.SW)
Swiss - Swiss Delayed Price. Currency in CHF
Add to watchlist
At close: 05:30PM CEST
| Previous close | 319.00 |
| Open | 317.30 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 317.15 - 324.50 |
| 52-week range | 302.40 - 404.20 |
| Volume | |
| Avg. volume | 1,547,526 |
| Market cap | 280.394B |
| Beta (5Y monthly) | 0.31 |
| PE ratio (TTM) | 19.90 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 9.30 (2.92%) |
| Ex-dividend date | 17 Mar 2022 |
| 1y target est | N/A |
- Zacks
Pharma Stock Roundup: PFE's Biohaven Buyout Offer, BAYRY's Q1 Earnings Update
Pfizer (PFE) is set to buy migraine drugmaker, Biohaven Pharmaceuticals for $11.6 billion. Bayer (BAYRY) beats Q1 earnings and sales expectations.
- Zacks
Roche (RHHBY) Phase III NSCLC Study Disappoints, Stock Down
Roche (RHHBY) stock declines as the late-stage study evaluating tiragolumab plus Tecentriq fails to meet its co-primary endpoint of progression-free survival.
- Zacks
Epizyme (EPZM) Q1 Earnings Miss, Revenues Lag Estimates
Epizyme (EPZM) posts a wider-than-expected loss for the first quarter. Revenues also miss estimates. EPZM has multiple pipeline readouts on track for this year.
© 2022 Yahoo. All rights reserved.
